Drug data last refreshed 8h ago · AI intelligence enriched 6d ago
OXYGEN, USP is a pharmaceutical-grade oxygen gas administered via inhalation to treat hypoxemia and respiratory insufficiency in patients requiring supplemental oxygen therapy. As a simple molecule essential for cellular respiration, oxygen restores adequate arterial oxygen saturation in patients with acute or chronic respiratory compromise.
Oxygen USP operates in a mature, essential-care market with stable demand and moderate competitive pressure (30), typical of commoditized respiratory therapies with limited growth upside.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
MolecuLight All-in-One Oxygenation Clinical Utility
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on Oxygen USP offers stable, essential-care career opportunities in regulatory compliance, manufacturing excellence, and healthcare logistics rather than commercial growth or innovation. Roles emphasize operational reliability, quality standardization, and supply reliability in a commodity market with predictable demand.